MAINtenance of remission with RITuximab versus azathioprine for patients with newly-diagnosed or relapsing Eosinophilic Granulomatosis with polyangiitis.
A prospective, randomized, controlled, double-blind study: the MAINRITSEG trial.
Contact: xavier.puechal@aphp.fr
Mis à jour le 29 juillet 2020
